Results 121 to 130 of about 164,484 (166)
Some of the next articles are maybe not open access.

Particle Beams for Cancer Therapy

Clinical Oncology, 2003
Particle beams from protons to carbon ions have a number of important advantages for radiation therapy. Besides the physical selectivity that makes ions especially efficient for deep-seated tumours and tumours close to critical organs, carbon ions with their enhanced relative biological effectiveness offer an additional biological advantage for slow ...
W K, Weyrather, J, Debus
openaire   +2 more sources

Radiation Therapy With Charged Particles

Seminars in Radiation Oncology, 2006
Charged particle beams can offer an improved dose conformation to the target volume as compared with photon radiotherapy, with better sparing of normal tissue structures close to the target. In addition, beams of ions heavier than (4)He exhibit a strong increase of the linear energy transfer in the Bragg peak as compared with the entrance region. These
Daniela, Schulz-Ertner   +2 more
openaire   +2 more sources

Particle-Mediated Gene Therapy of Wounds

Wound Repair and Regeneration, 2000
Gene therapy is becoming a reality, and it is a particularly attractive approach for wound healing, because the wound site is often exposed, the treatment and condition should be transient, and gene products such as growth factors and cytokines suffer from problems with bioavailability and stability.
J M, Davidson, T, Krieg, S A, Eming
openaire   +3 more sources

Antiviral therapy with small particle aerosols

European Journal of Clinical Microbiology & Infectious Diseases, 1988
The generation and use of small particle aqueous aerosols (1.23 microns aerodynamic mass median diameter, GSD = 2.0 microns) containing ribavirin is described. Administered via aerosol, ribavirin will be deposited rather uniformly on the surface of the nasopharynx, the tracheobronchial tree and in the pulmonary area.
V, Knight, B, Gilbert
openaire   +2 more sources

Alpha-particles for targeted therapy

Advanced Drug Delivery Reviews, 2008
Alpha-particles are helium nuclei that deposit DNA damaging energy along their track that is 100 to 1000 times greater than that of conventionally used beta-particle emitting radionuclides for targeted therapy; the damage caused by alpha-particles is predominately double-stranded DNA breaks severe enough so as to be almost completely irreparable.
openaire   +2 more sources

The case for particle therapy

The British Journal of Radiology, 2006
Among the most important decisions facing the British Government regarding the treatment of cancer in the National Health Service (NHS) is the purchase of charged particle therapy (CPT) centres. CPT is different from conventional radiotherapy: the dose is deposited far more selectively in Bragg Peaks by either protons or "heavy" ions, such as carbon ...
openaire   +2 more sources

Basics of Particle Therapy

American Journal of Clinical Oncology, 2008
With the arrival of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy, radiation dose distributions in radiation oncology have improved dramatically over the past couple of decades. As part of a natural progression there recently has been a resurgence of interest in hadron therapy, specifically charged particle therapy,
openaire   +2 more sources

Percutaneous Transcatheter Particle Therapies

2019
Given that only 20–30% of patients with hepatocellular carcinoma and colorectal liver metastases present with resectable disease, there has been an increasing role for the use of percutaneous transcatheter particle therapies in the management of unresectable hepatic malignancies.
Grace C. Lee   +2 more
openaire   +1 more source

Particle radiation therapy.

Cancer, 1976
Particle radiation therapy has the potential for immediate and sustained favorable impact on management of the cancer patient by providing better local tumor control. Scientific knowledge and expertise are immediately available to mount effective clinical studies of fast neurons, protons, and helium ions, and to initiate necessary preliminary studies ...
openaire   +1 more source

Targeted α-Particle Therapy

2005
The role of monoclonal antibodies (MAbs) in the treatment of malignancies has increased dramatically over the past decade. Three unlabeled MAbs—rituximab (Rituxan; IDEC Pharmaceuticals, San Diego, CA, and Genentech, Inc., South San Francisco, CA), trastuzumab (Herceptin; Genentech, Inc., South San Francisco, CA), and alemtuzumab (Campath-1H; Burroughs ...
John M. Burke   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy